Tezspire has been recommended as an add-on therapy for these patients whose condition is not sufficiently controlled with high dose inhaled corticosteroids besides another medicinal product for maintenance
The post CHMP recommends AstraZeneca’s Tezspire for approval to treat severe asthma appeared first on Pharmaceutical Business review.